Literature DB >> 2344447

High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein.

S Parthasarathy1, J Barnett, L G Fong.   

Abstract

Oxidatively modified low-density lipoprotein (LDL), generated as a result of incubation of LDL with specific cells (e.g., endothelial cells, EC) or redox metals like copper, has been suggested to be an atherogenic form of LDL. Epidemiological evidence suggests that higher concentrations of plasma high-density lipoprotein (HDL) are protective against the disease. The effect of HDL on the generation of the oxidatively modified LDL is described in the current study. Incubation of HDL with endothelial cells, or with copper, produced much lower amounts of thiobarbituric acid-reactive products (TBARS) as compared to incubations that contained LDL at equal protein concentrations. Such incubations also did not result in an enhanced degradation of the incubated HDL by macrophages in contrast to similarly incubated LDL. On the other hand, inclusion of HDL in the incubations that contained labeled LDL had a profound inhibitory effect on the subsequent degradation of the incubated LDL by the macrophages while having no effect on the generation of TBARS or the formation of conjugated dienes. This inhibition was not due to the modification of HDL as suggested by the following findings. (A) There was no enhanced macrophage degradation of the HDL incubated with EC or copper alone, together with LDL, despite an increased generation of TBARS. (B) HDL with the lysine groups blocked (acetyl HDL, malondialdehyde (MDA) HDL) was still able to prevent the modification of LDL and (C) acetyl HDL and MDA-HDL competed poorly for the degradation of oxidatively modified LDL. It is suggested that HDL may play a protective role in atherogenesis by preventing the generation of an oxidatively modified LDL. The mechanism of action of HDL may involve exchange of lipid peroxidation products between the lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344447     DOI: 10.1016/0005-2760(90)90314-n

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  116 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Response of plasma lipids to dietary cholesterol and wine polyphenols in rats fed polyunsaturated fat diets.

Authors:  L Frémont; M T Gozzelino; A Linard
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

4.  Oxidative modification and poor protective activity of HDL on LDL oxidation in thalassemia.

Authors:  Supeenun Unchern; Narumon Laohareungpanya; Yupin Sanvarinda; Kovit Pattanapanyasat; Pansakorn Tanratana; Udom Chantharaksri; Nathawut Sibmooh
Journal:  Lipids       Date:  2010-06-09       Impact factor: 1.880

5.  Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins.

Authors:  S T Kunitake; M R Jarvis; R L Hamilton; J P Kane
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

Review 7.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

8.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

9.  Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells.

Authors:  J M Heery; M Kozak; D M Stafforini; D A Jones; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

Review 10.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.